Binaschi, Monica,Bigioni, Mario,Merlino, Giuseppe,Simonelli, Cecilia,Bertoni, Francesco,Pellacani, Andrea
申请号：
AU2018232886
公开号：
AU2018232886A1
申请日:
2018.03.09
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present disclosure relates generally to the fields of immunology and molecular biology. More specifically, provided herein are pharmaceutical combinations comprising (A) antibodies, or antigen-binding portions thereof, directed against LY75, and (B) a second anti-cancer entity； nucleic acids encoding antibody combinations； methods for preparing antibody combinations； and methods for the treatment of diseases, such as cancers mediated by LY75 expression or activity.
